Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide and tirzepatide, have rapidly reshaped the management of type 2 diabetes and obesity. Their ability to lower blood glucose, reduce body weight, and modulate appetite has been hailed as a therapeutic breakthrough. But as these agents move from niche to mainstream, clinicians across disciplines are discovering their broader […]
Recent Posts
- Nobel Prize 2025: Immune System Pioneers Honored – A Triumph for Medical Science with Lessons for Dentistry
- How Oral Bacteria May Predict Pancreatic Cancer: New Research Insights
- Mercury-Free Dental Restorations: The 2025 Amalgam Shift
- Complications in Dental Implantology: A Stepwise Perspective
- Managing Unparallel Teeth in Dental Bridges: Solutions for Optimal Alignment
Archives